«The Army was able to move so quickly in developing, manufacturing and testing a Zika
vaccine because of its extensive experience with this
vaccine platform and long standing investments in the understanding and mitigation of
flaviviruses, like yellow fever, dating back to the founding of WRAIR,» said Dr. Kayvon Modjarrad, Zika program co-lead and associate director for Emerging Infectious Disease Threats at WRAIR's MHRP.